rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Susan Moran

Director

Company insider

Files Form 4 as: Director, Crescent Biopharma; Director, Tyra Biosciences; Director, BioAtla; Chief Medical Officer, RayzeBio.

Every Form 4 they filed

In numbers

Trades disclosed
20
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
3
First trade
15 Jun 2021
Last trade
2 Jun 2026
Last filed
3 Jun 2026

Companies traded

Where they are an officer
RayzeBioOfficer · last 26 Feb 20240 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CBIO Crescent BiopharmaDirector · Biotechnology · last 2 Jun 20260 buys · 0 sells
TYRA Tyra BiosciencesDirector · Biotechnology · last 28 May 20260 buys · 0 sells
BioAtlaDirector · Biotechnology · last 18 Jun 20250 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jun 2026filed 3 Jun 2026CBIO Crescent Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—11,050 at $0.00filing
2 Jun 2026filed 3 Jun 2026CBIO Crescent Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—11,050 at $0.00filing
28 May 2026filed 1 Jun 2026TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—13,160 at $0.00filing
28 May 2026filed 1 Jun 2026TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—13,160 at $0.00filing
23 Jun 2025filed 23 Jun 2025CBIO Crescent Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—9,023 at $0.00filing
18 Jun 2025filed 18 Jun 2025BioAtlaBiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
29 May 2025filed 2 Jun 2025TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—22,200 at $0.00filing
13 Jun 2024filed 14 Jun 2024BioAtlaBiotechnologySEC FORM 4 Code A—16,500 at $0.00filing
7 May 2024filed 9 May 2024TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—37,200 at $0.00filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—60,757filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—77,805filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—194,514filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—164,000filing
26 Feb 2024filed 27 Feb 2024RayzeBioSEC FORM 4 Code D$20.2M323,455 at $62.50filing
22 Jan 2024filed 6 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code M—30,875 at $0.00filing
22 Jan 2024filed 6 Feb 2024RayzeBioSEC FORM 4 Code M$100K30,875 at $3.24filing
17 Nov 2023filed 17 Nov 2023RayzeBiooption or derivativeSEC FORM 4 Code A—164,000 at $0.00filing
14 Jun 2023filed 15 Jun 2023BioAtlaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
16 Jun 2022filed 17 Jun 2022BioAtlaoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
15 Jun 2021filed 16 Jun 2021BioAtlaoption or derivative · BiotechnologySEC FORM 4 Code A—12,307 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.